NCT00386698View on ClinicalTrials.gov

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix

BIOLOGICAL

adjuvanted influenza vaccine

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY